APA (7th ed.) Citation

DO, O., JO, M., LN, N., S, A., T, M., J, K., . . . SM, L. (2026). Outcomes of the Three-month Weekly Isoniazid With Rifapentine (3HP) Versus the Six-month Isoniazid Preventive Therapy (6H) Among People Newly Enrolled in HIV Care in Western Kenya. Open forum infectious diseases, 13(7), ofag416. https://doi.org/10.1093/ofid/ofag416

Chicago Style (17th ed.) Citation

DO, Onyango, Mecha JO, Njagi LN, Aoro S, Malika T, Kinuthia J, John-Stewart G, and LaCourse SM. "Outcomes of the Three-month Weekly Isoniazid With Rifapentine (3HP) Versus the Six-month Isoniazid Preventive Therapy (6H) Among People Newly Enrolled in HIV Care in Western Kenya." Open Forum Infectious Diseases 13, no. 7 (2026): ofag416. https://doi.org/10.1093/ofid/ofag416.

MLA (9th ed.) Citation

DO, Onyango, et al. "Outcomes of the Three-month Weekly Isoniazid With Rifapentine (3HP) Versus the Six-month Isoniazid Preventive Therapy (6H) Among People Newly Enrolled in HIV Care in Western Kenya." Open Forum Infectious Diseases, vol. 13, no. 7, 2026, p. ofag416, https://doi.org/10.1093/ofid/ofag416.